U.S. markets closed

Medical Marijuana, Inc. (MJNA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0310+0.0003 (+0.98%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0307
Open0.0307
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0300 - 0.0321
52 Week Range0.0100 - 0.2200
Volume6,184,751
Avg. Volume13,614,131
Market Cap106.775M
Beta (5Y Monthly)0.01
PE Ratio (TTM)15.50
EPS (TTM)0.0020
Earnings DateAug 23, 2021 - Aug 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies
    GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies

    MJNA Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a brand new product to complement its extensive product l

  • Medical Marijuana, Inc. Subsidiary HempMeds® Latin American Operations Achieves Best Revenue Month Ever in June 2021
    GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Latin American Operations Achieves Best Revenue Month Ever in June 2021

    SAN DIEGO, CA, July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Latin American operations of its subsidiary HempMeds® achieved its best revenue month ever in the history of the Company in June 2021. In Latin America, the Company increased its rev

  • Medical Marijuana, Inc. Subsidiary HempMeds® Applauds Mexico’s Supreme Court for Decriminalizing Cannabis
    GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Applauds Mexico’s Supreme Court for Decriminalizing Cannabis

    SAN DIEGO, CA, July 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® applauds Mexico’s Supreme Court for its decision to deem a set of laws which criminalized the recreational adult use of cannabis in Mexico unconstitutional, and